News

Acumen Pharmaceuticals, Inc.: Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery ...
Acumen and JCR aim to develop a product leveraging Acumen's amyloid beta oligomer-selective antibody expertise and JCR's transferrin-receptor-targeting blood-brain barrier-penetrating technologyPrecli ...
The Brighterside of News on MSN20h
Scientists use brain imaging to spot early signs of Alzheimer’s
Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...
AlzeCure Pharma: AlzeCure's Pain Project ACD440 Granted Orphan Drug Status in the US by the FDA
STOCKHOLM, SE / ACCESS Newswire / July 15, 2025 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases ...
Revealed: The bombshell new drug that could delay the menopause for years - or even eliminate it forever... but are you willing to put up with these side effects?
Whether women want it or not, they have little choice but to go through the menopause . Or do they? What if the menopause was ...
Naturopathic Doctor News and Review31m
Tauroursodeoxycholic Acid (TUDCA) And Protective Role Against Neurodegeneration
Emerging research positions TUDCA, a bile acid compound, as a promising neuroprotective agent against Alzheimer’s, ...
Explained Interview | After obesity and diabetes, where GLP-1 research is headed
Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...